Related Experiment Videos

Growth of Staphylococcus aureus in four intravenous anesthetics

M B Sosis1, B Braverman

  • 1Department of Anesthesiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612.

Anesthesia and Analgesia
|October 1, 1993
PubMed

Insights

Propofol supports rapid Staphylococcus aureus growth, unlike other anesthetics or saline. Strict sterile techniques are crucial when handling propofol to prevent patient infections.

Area of Science:

  • Anesthesiology
  • Microbiology
  • Infection Control

Background:

  • Patient infections linked to propofol use have been documented.
  • Understanding microbial growth in anesthetic agents is critical for patient safety.

Purpose of the Study:

  • To investigate the in vitro growth of Staphylococcus aureus in propofol.
  • To compare S. aureus growth in propofol versus other anesthetics (thiopental, methohexital, etomidate) and 0.9% saline.

Main Methods:

  • Inoculation of propofol, thiopental, methohexital, etomidate, and 0.9% saline with Staphylococcus aureus.
  • Sampling at multiple time points (0, 3, 6, 21, 24, 27 hours) and plating on blood agar.
  • Determination of colony-forming units (CFU) after 24-hour incubation.

Main Results:

  • Propofol demonstrated substantial S. aureus growth between 6 and 21 hours post-inoculation.
  • Etomidate showed rapid bacterial elimination (zero CFU by 3 hours).
  • Methohexital and thiopental required 21 hours for complete bacterial elimination.
  • 0.9% saline showed a gradual decline in CFU, with some remaining at 27 hours.

Conclusions:

  • Propofol serves as an excellent growth medium for Staphylococcus aureus.
  • Rigorous sterile techniques are essential during propofol handling to mitigate infection risks.

Related Concept Videos